As of Aug 03
| -1.39 / -7.71%|
The 8 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 13.50, with a high estimate of 24.00 and a low estimate of 5.25. The median estimate represents a -18.82% decrease from the last price of 16.63.
The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.